A Florida-based company is attempting to combat the aging process by harvesting the blood of young people and transfusing it into patients 30 years old and over in a dubious new fad sweeping the US.
Ambrosia, founded in 2016 by Stanford Medical School graduate Jesse Karmazin, has already established transfusion centers in five cities across the US: Los Angeles, Tampa, Omaha, Houston, and San Francisco. Their ghoulish-sounding treatments start at just $ 8,000 for one liter and $ 12,000 for two.
The blood donors range from 16 to 25, while patients fall into the over 30s bracket. So far, roughly 150 patients aged 35 to 92 have reportedly undergone the "young plasma treatments," and the company claims a waiting list has already been formed
"Some patients got young blood, and others got older blood, and I was able to do some statistics on it, and the results looked really awesome, " Karmazin said earlier. "And I thought this is the kind of therapy that I would want to be available to me."
The idea was inspired by an experimental treatment called 'parabiosis' showed a reduction in two proteins associated with cancer risk, although the study was both inconclusive and limited in scope.
The company conducted a clinical trial involving 200 participants from June 2016 to January 2018.
"The trial was an experimental study" David Cavalier, Ambrosia's former chief operating officer, said in September. "We've seen some interesting things, and we plan to publish that data. "
The company lists nebulous and ill-defined health benefits in patients such as " renewed focus, better memory and sleep, and improved appearance and muscle tone, " but has yet to provide any empirical data to back up these claims.
In addition, blood transfusions are listed as "off-label" treatments by the Food and Drug Administration, "" They quite likely could cause bodily harm, " UC Berkeley researcher Irina Conboy warned to Business Insider. "It is well known in the medical community – and this is why we do not transfusions frequently – that in 50 percent of patients there are very bad side effects. You are being infused with someone else's blood and it does not match. "
Like this story? Share it with a friend!